When two top executives from Cred LLC got hit with prison sentences this week, it was another reminder of how brutal crypto fraud can be.When two top executives from Cred LLC got hit with prison sentences this week, it was another reminder of how brutal crypto fraud can be.

Cred Execs Jailed After $140M Fraud – Why Best Wallet Token ($BEST) Is the Safer Crypto Bet

Cred Execs Jailed After $140M Fraud – Why Best Wallet Token ($BEST) Is the Safer Crypto Bet

The company collapsed back in 2020, leaving customers stranded.

Fast forward to today, and more than 6K claims worth $140M have piled up, now valued at over $1B. That’s not just numbers on a page – it’s the life savings, college funds, and retirement plans of real people.

If you’ve ever worried about where to keep your crypto safe, now’s the time to pay attention.

The Lesson From Cred’s Collapse

Cred’s downfall wasn’t some minor misstep. Daniel Schatt, the 55-year-old CEO, and Joseph Podulka, the 53-year-old CFO, pleaded guilty to wire fraud conspiracy in May 2025.

On August 30, they were sentenced: Schatt will serve 52 months, Podulka 36 months, plus fines and supervised release.

Prosecutors say they hid tens of millions in losses during the COVID-19 market crash, all while reassuring customers that ‘everything was operating normally.’

Acting FBI Special Agent in Charge Matt Cobo quote.

By October 28, both will be behind bars. But the damage was already done.

The case highlights the hard truth: trusting centralized lending firms is risky. When companies over-promise, customers pay the price.

Instead of leaving funds in someone else’s hands, many investors are now looking for safer ways to protect their assets, and that’s where innovative projects like Best Wallet Token come into play.

What Best Wallet Token ($BEST) Brings to the Table

Best Wallet Token ($BEST) is the engine behind Best Wallet’s rise. It’s the fuel that powers an entire ecosystem of perks, access, and rewards.

At the most basic level, holding $BEST gives users cheaper transaction fees and better staking yields.

But it goes further – the token also unlocks early access to new crypto projects, and even a voice in ecosystem governance. In other words, $BEST is designed to make loyal users feel like insiders.

best wallet token benefits.

One of the standout utilities is its role in Upcoming Tokens, Best Wallet’s game-changing presale tool. Investors can participate in new crypto presales directly in the app, using $BEST to secure access without the usual risks of scam sites.

This turns $BEST into more than a currency, it becomes a passport into some of the hottest early-stage deals in crypto.

With $15.3M already raised and a growing 70K-strong following on social media, $BEST is carving out its place among the best altcoins of 2025.

Why Investors Are Buying Into $BEST

In the wake of cases like Cred’s $140M fraud, investors aren’t just looking for hype – they want tokens tied to real-world utility and security.

That’s exactly what $BEST offers. At today’s presale price of just $0.025555, it’s still early enough to catch before wider demand drives valuations higher.

buy best wallet token presale now.

Unlike meme coins, which ride short-term waves, $BEST is linked to core features people actually use: trading, staking, and presale access.

That built-in demand keeps buyers coming back, creating a token economy with staying power. It’s no wonder many see $BEST not only as one of the best crypto presales happening now but also as a strong contender for long-term growth.

Why $BEST Stands Out After Cred’s Collapse

The Cred fraud case shows what happens when trust is misplaced. But the crypto world is moving forward, and projects like Best Wallet Token are building tools that give power back to the user.

If you’re serious about keeping your coins safe while staying connected to the fastest-growing parts of crypto, $BEST might be worth a closer look.

Market Opportunity
TokenFi Logo
TokenFi Price(TOKEN)
$0.004703
$0.004703$0.004703
-4.44%
USD
TokenFi (TOKEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26